Delivery Order SPE2DB22D1017-SPE2DB25FYQMM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.65 firm fixed-price delivery order is for the supply of Granisetron HCL 1 mg tablets to support military healthcare programs. The contract has a completion date of May 20, 2024 and was awarded on May 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Granisetron HCL 1 mg Tablets in 20-count units, with a ceiling value of $50,326.20 and a period of performance through January 16, 2025. There was no set-aside designation for this open-competition contract award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,810.72 firm fixed-price delivery order is for the supply of granisetron HCL 1 mg tablets, with a period of performance through October 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron Hydrochloride 1 mg tablets. The $7,864.04 firm fixed-price contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,262.79 firm-fixed-price delivery order is for the supply of 4,565,056,096 units of Granisetron HCl 1 mg Tablet UD 20s, a medication used for the prevention of nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Granisetron HCL 1 mg tablets. The contract has a ceiling value of $1,696.43 and a performance period ending on April 11, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,046.92 contract is for the supply of 4,563,631,434 units of the pharmaceutical drug Granisetron Hydrochloride 1 mg Tablets. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
- This delivery order for $6,752.67, awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, is for 20 boxes of the generic drug Granisetron HCl in 1 mg tablets. The place of performance is Conshohocken, Pennsylvania, and the completion date is October 24, 2023. It was awarded on October 23, 2023 as a firm fixed price order with no set-aside designation. Amerisourcebergen will deliver the generic antiemetic medication to the Defense Logistics Agency to support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,162.26, is for the delivery of granisetron HCL 1 mg tablet units. It is a firm fixed-price delivery order contract with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,790.07, is for the delivery of 4567631605 - Granisetron HCl 1 mg Tablet UD 20s. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQMMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Granisetron HCL 1 mg tablets in unit dose packages of 20 units, with a ceiling value of $1,526.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. Granisetron HCL, an antiemetic medication commonly used in military and veteran healthcare settings, represents one of many pharmaceutical products available through this strategic contract vehicle, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/11/25 |